Study of Vasomotor Symptoms in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen

Trial Profile

Study of Vasomotor Symptoms in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen

Completed
Phase of Trial: Phase II

Latest Information Update: 29 Mar 2014

At a glance

  • Drugs Raloxifene (Primary) ; Estradiol
  • Indications Vasomotor symptoms
  • Focus Therapeutic Use
  • Sponsors Eli Lilly
  • Most Recent Events

    • 29 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top